AbbVie (Spain)

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt et al. · The Lancet · 2017 · 883 citations

Gastroenterology, Tight Control Management, Clinical Gastroenterology +3

Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada

Kevin Robertson, Carmen Bayón, Jean‐Michel Molina et al. · AIDS Care · 2014 · 111 citations · Full text

Counseling, Psychological Co-morbidities, Psychiatric Evaluation +21

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial

Andrew J.K. Östör, Filip Van den Bosch, Kim Papp et al. · Annals of the Rheumatic Diseases · 2021 · 100 citations · Full text

Ultrasound as a diagnostic and management tool in hidradenitis suppurativa patients: a multicentre study

Antonio Martorell, Fernando Alfageme, E. Vilarrasa Rull et al. · Journal of the European Academy of Dermatology and Venereology · 2019 · 87 citations · Full text

Open : Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-up in the PYRAMID Registry

Geert D’Haens, Walter Reinisch, Remo Panaccione et al. · The American Journal of Gastroenterology · 2018 · 72 citations · Full text